AbCellera Biologics Inc. (ABCL) at a glance

AbCellera Biologics Inc. (ABCL) is a small-cap Healthcare company. It trades at $11.35, with a -181.7% profit margin and revenue growth of 96.3%. It does not pay a dividend. Vestovix scores it 59/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Income (40/100).

Price
$11.35
Market cap
$1.60B
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$2.75 to $12.58
Vestovix Score59/ 100How this works
Value
43
Growth
94
Income
40
Safety
46
Momentum
78

Other Healthcare stocks

See all